Table 7.
Multivariate analysis of breast-cancer survival
| Included parameters |
Disease-free survival |
Overall survival |
||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | P -value | Hazard ratio | 95% CI | P -value | |
| T stage |
|
|
0.014 |
|
|
0.040 |
| T1 versus T2-3 |
2.123 |
1.167-3.861 |
|
1.829 |
1.028-3.255 |
|
| N stage |
|
|
0.001 |
|
|
0.011 |
| N0 versus N1-3 |
2.344 |
1.389-3.956 |
|
1.971 |
1.166-3.333 |
|
| Histologic grade |
|
|
0.632 |
|
|
0.545 |
| I/II versus III |
1.143 |
0.661-1.977 |
|
0.839 |
0.475-1.482 |
|
| ER status |
|
|
0.111 |
|
|
0.079 |
| Negative versus Positive |
1.795 |
0.874-3.686 |
|
1.888 |
0.929-3.836 |
|
| PR status |
|
|
0.198 |
|
|
0.070 |
| Negative versus Positive |
1.638 |
0.773-3.473 |
|
2.036 |
0.944-4.393 |
|
| HER-2 status |
|
|
0.469 |
|
|
0.508 |
| Negative versus Positive |
1.235 |
0.697-2.188 |
|
1.214 |
0.683-2.159 |
|
| GNMT |
|
|
0.019 |
|
|
0.272 |
| Negative versus Positive |
2.408 |
1.154-5.024 |
|
1.622 |
0.684-3.849 |
|
| PIPOX (T) |
|
|
0.069 |
|
|
0.563 |
| Negative versus Positive | 0.457 | 0.196-1.064 | 0.810 | 0.397-1.652 | ||
Bold number represents p<0.05.